Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Revenue Recognition (Details)

v3.10.0.1
Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenue $ 2.1    
Research Agreement | Multinational Pharmaceutical Company | Before topic 606      
Revenue   $ 1.1 $ 0.3